Granulocyte-colony stimulating factor - sublingual - Vitapharm

Drug Profile

Granulocyte-colony stimulating factor - sublingual - Vitapharm

Alternative Names: Filgrastim biobetter - VitaPharm; G-CSF sublingual

Latest Information Update: 06 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Vitapharm Technology Development
  • Class Biobetters; Granulocyte colony-stimulating factors
  • Mechanism of Action Granulocyte colony stimulating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Neutropenia

Most Recent Events

  • 06 Sep 2017 Discontinued - Preclinical for Neutropenia in China (Sublingual)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Neutropenia in China (Sublingual, Tablet)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top